188 related articles for article (PubMed ID: 30892090)
1. Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics.
Bhattacharya R; Harvey RA; Abraham K; Rosen J; Mehta P
Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):251-259. PubMed ID: 30892090
[No Abstract] [Full Text] [Related]
2. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.
Williams JR; Fitzhenry D; Grant L; Martyn D; Kerr DA
BMC Neurol; 2013 Nov; 13():160. PubMed ID: 24499173
[TBL] [Abstract][Full Text] [Related]
5. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
7. Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly.
Freedman DM; Kuncl RW; Cahoon EK; Rivera DR; Pfeiffer RM
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):538-546. PubMed ID: 31112080
[TBL] [Abstract][Full Text] [Related]
8. Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs.
Pfeiffer RM; Mayer B; Kuncl RW; Check DP; Cahoon EK; Rivera DR; Freedman DM
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):235-245. PubMed ID: 31684770
[No Abstract] [Full Text] [Related]
9. Study of 962 patients indicates progressive muscular atrophy is a form of ALS.
Kim WK; Liu X; Sandner J; Pasmantier M; Andrews J; Rowland LP; Mitsumoto H
Neurology; 2009 Nov; 73(20):1686-92. PubMed ID: 19917992
[TBL] [Abstract][Full Text] [Related]
10. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives.
Gordon PH; Mehal JM; Holman RC; Rowland LP; Rowland AS; Cheek JE
JAMA Neurol; 2013 Apr; 70(4):476-80. PubMed ID: 23440294
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.
Körner S; Kollewe K; Ilsemann J; Müller-Heine A; Dengler R; Krampfl K; Petri S
Eur J Neurol; 2013 Apr; 20(4):647-54. PubMed ID: 23094606
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015.
Mehta P; Kaye W; Raymond J; Punjani R; Larson T; Cohen J; Muravov O; Horton K
MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(46):1285-1289. PubMed ID: 30462626
[TBL] [Abstract][Full Text] [Related]
13. Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers.
Nakken O; Lindstrøm JC; Tysnes OB; Holmøy T
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):303-310. PubMed ID: 29271248
[TBL] [Abstract][Full Text] [Related]
14. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015.
Punjani R; Wagner L; Horton K; Kaye W
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):123-130. PubMed ID: 31795746
[TBL] [Abstract][Full Text] [Related]
15. Natural history of young-adult amyotrophic lateral sclerosis.
Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of creating a National ALS Registry using administrative data in the United States.
Kaye WE; Sanchez M; Wu J
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):433-9. PubMed ID: 24597459
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
18. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.
Haverkamp LJ; Appel V; Appel SH
Brain; 1995 Jun; 118 ( Pt 3)():707-19. PubMed ID: 7600088
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.
Mehal JM; Holman RC; Schonberger LB; Sejvar JJ
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):346-52. PubMed ID: 23621426
[TBL] [Abstract][Full Text] [Related]
20. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
